Alpine Immune Sciences Stock (NASDAQ: ALPN) stock price, news, charts, stock research, profile.
Open | $64.670 |
Close | $64.820 |
Volume / Avg. | 1.141M / 2.277M |
Day Range | 64.650 - 64.850 |
52 Wk Range | 7.250 - 64.720 |
Market Cap | $4.249B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 83 |
Short Interest | 10.09% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alpine Immune Sciences (NASDAQ: ALPN) through any online brokerage.
Other companies in Alpine Immune Sciences’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
The latest price target for Alpine Immune Sciences (NASDAQ: ALPN) was reported by TD Cowen on Tuesday, April 16, 2024. The analyst firm set a price target for 0.00 expecting ALPN to fall to within 12 months (a possible -100.00% downside). 30 analyst firms have reported ratings in the last year.
The stock price for Alpine Immune Sciences (NASDAQ: ALPN) is $64.81 last updated Today at May 9, 2024 at 5:09 PM EDT.
There are no upcoming dividends for Alpine Immune Sciences.
Alpine Immune Sciences’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Alpine Immune Sciences.
Alpine Immune Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.